GP120, HIV-1 MN
GP120, HIV-1 MN is a peptide. GP120, HIV-1 MN can be used for the research of HIV infection.
For research use only. We do not sell to patients.
- Formula: C135H221N45O33
- Molecular Weight:3002.48
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Chemical Information
-
Molecular Weight 3002.48
-
Formula C135H221N45O33
-
Sequence
Tyr-Asn-Ala-Lys-Arg-Lys-Arg-Ile-His-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Tyr-Thr-Thr-Lys-Asn-Ile-Ile
-
Sequence Shortening
YNAKRKRIHIQRGPGRAFYTTKNII
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. R P Weissburg, et al. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Pharm Res. 1995 Oct;12(10):1439-46. [Content Brief]
[2]. R B Belshe, et al. Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group. AIDS. 1998 Dec 24;12(18):2407-15. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
GP120, HIV-1 MN Related Classifications
HY-P4055 Related Classifications
Powered by Bioz